Feature Channels:

Pharmaceuticals

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Cancer, Radiology, Nephrology, Kidney, Contrast-induced-nephropathy, CIN, Contrast Media, Iodine, iodated contrast media, Oncology, Patient Safety, Healthcare, Sbarro Health Research Organization

Does Radiology Contrast Medium Matter? To Fragile Cancer Patients, Yes

Given the choice of contrast medium for a computed tomography (CT) scan, most patients wouldn’t know the difference between the two iodine-based options commonly used in cancer cases. But for some patients, particularly in the already fragile and potentially compromised cancer patient, it is important to be aware that iodated contrast media has been linked to kidney impairment and a condition known as Contrast-induced nephropathy (CIN).

Medicine

Channels:

Yale Cancer Center, Lung Cancer, Pancreatic Cancer, Head And Neck Cancer, Melanoma, Aspirin

Aspirin: Wonder Drug for Cancer Prevention?

Many are finding that aspirin can slow or prevent one of mankind's deadliest diseases: cancer. While the mechanism is still debated, some experts say aspirin reduces the inflammation that drives cancer.

Medicine

Life

Social and Behavioral Sciences

Channels:

Why Are Doctors Underusing a Drug to Treat Opioid Addiction?

Access to counseling for patients, mentoring for physicians could help increase use, survey says

Life

Law and Public Policy

Channels:

Healthcare, Pharmaceutical Industry, 21st century cures act

21st Century Cures Act Passage Highlights Need for Improved Comment Period

The 21st Century Cures Act, approved by Congress in December 2016, authorized $6.3 billion in federal funding, mainly for the National Institutes of Health (NIH). It was supported in large part by pharmaceutical manufacturers.The bill and key changes made during its drafting remain controversial and show the need for a more informed comment period for future health care legislation, says an expert on health law at Washington University in St.

Medicine

Channels:

John Schuetz, St. Jude Children's Research Hospital, Pharmaceutical Science, AML, Acute Myeloid Leukemia, heme synthesis, HEME, JCI Insight, MYCN, UROD

Discovery Points to Drugs That Would ‘Short-Circuit’ Deadly Leukemia

St. Jude Children’s Research Hospital scientists have found that cells of a deadly acute myeloid leukemia can be killed by blocking production of a molecular “battery.”

Medicine

Channels:

Mark Bicket, Peter Pronovost, Opioid, Drugs, Perscription

Study Adds to Evidence That Most Prescribed Opioid Pills Go Unused

Opioid_Addiction_Pill_iStock-155132832.jpg

In a review of half a dozen published studies in which patients self-reported use of opioids prescribed to them after surgery, researchers at Johns Hopkins report that a substantial majority of patients used only some or none of the pills, and more than 90 percent failed to dispose of the leftovers in recommended ways.

Medicine

Channels:

PharmaVOICE 100

ISPOR Leaders Named PharmaVOICE 100 Honorees

PharmaVOICE100_Cover.png

Two ISPOR leaders have been named to the renowned list of 2017 PharmaVOICE 100 honorees. Immediate Past-President Lou Garrison, PhD and Chief Executive Officer and Executive Director Nancy S. Berg have been named 2017 PharmaVOICE 100 honorees by PharmaVOICE magazine.

Science

Channels:

Parkinson's Disease, Drugs, Medicine, Medication, Compound, Ropinirole, Dopamine, Disease Progression, Disease, Dyskinesia, Therapeutic, Antioxidant, Binghamton, Binghamton University, SUNY Binghamton, State University of New York at Binghamton

New Drug May Treat and Limit Progression of Parkinson’s Disease

Researchers at Binghamton University have developed a new drug that may limit the progression of Parkinson’s disease while providing better symptom relief to potentially hundreds of thousands of people with the disease.

Medicine

Channels:

Cardiology, Heart Failure

Study Allays Concerns Over Aspirin’s Safety for Heart Failure Patients

A study by researchers at NewYork-Presbyterian/Columbia University Medical Center and published in JACC: Heart Failure, a journal of the American College of Cardiology Foundation, allays concerns among cardiologists that aspirin could increase the risk of hospitalization and death related to heart failure for patients with heart failure who take one of the first-line therapies: angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).

Medicine

Science

Channels:

Winning Star Trek Tricorder Device to Be Presented to Experts at the 69th AACC Annual Scientific Meeting

Press can register here to livestream this special session through Newswise Live on Monday, July 31 at 7:30 PM EDT. The winner of the Qualcomm Tricorder XPRIZE competition will present DxtER—a real-life tricorder—at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego. This special session will be the first time that the device is presented to researchers at a U.S. scientific conference.







Chat now!